S100A9 and disease of the tendon: This implies that S100A8/S100A9 modulates the inflammatory profile through a positive feedback mechanism, involving increased recruitment of leukocytes and the release of pro-inflammatory cytokines from tenocytes, sustaining the inflammatory response in the early stages of tendinopathy [52].